• >>
  • Pharmaceuticals and Healthcare

Dry Eye Syndrome Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240339
21st May, 2018
Region : Global
Pages
CHOOSE LICENCE TYPE

COVID-19


Understand the influence of COVID-19 on the Dry Eye Syndrome Market with our analysts monitoring the situation across the globe.






Description

Global Dry Eye Syndrome treatment report, by type (evaporative, aqueous), by diagnosis (Schirmer test, eye exam), treatment (nutritional supplements, surgery), end user (hospitals) - global forecast till 2025


Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS) is a condition that occurs when eye do not produces enough tears or the tears evaporate too quickly. Generally, the symptom of dry eye is mild but it can get painful and lead to complications. The common symptoms of DES are ocular irritation, photophobia, blurry vision, mucous discharge, ocular dryness, itching, and excessive tearing.  Tears are very important for our eyes; it provides lubrication, limits the risk of infection and helps in keeping the eyes clear. 


Diabetic patients are prone to DES. The growing geriatric population and increase in patients of disease such as diabetes others are the major driving factors of DES treatment. Additionally, the increasing awareness about latest treatment technology also boosts the growth of the market. Lack of nutrients in food also leads to DES.


However, high cost of treatment, lack of awareness about treatment, lack of skilled professionals and low expenditure per capita are the major restraints of the market.


Nevertheless, with increasing population, pollution is also increasing and the concern for healthcare is also growing which would keep the market healthy.


Market segmentation:

Dry eye syndrome market is segmented on the basis of type, diagnosis, treatment, end user and region


Based on type the market is classified as evaporative dry eye syndrome, aqueous dry eye syndrome, and others.


On the basis of diagnosis the market can be divided as Schirmer test, eye exam, and others.

Treatment wise the market can be classified as nutritional supplements, serum eye drops, lubricant eye drops, anti-inflammatory drugs segments, surgery, and others


As per end user the market is segmented as hospitals/clinics, ambulatory surgical centers, and others


Regional Analysis:

North America holds the maximum share of dry eye syndrome treatment market. This is attributed to their large patient pool and well developed healthcare technology. Moreover, presence of presence of the major market players like Johnson & Johnson Vision, Auven therapeutics, Acadia Pharmaceutical, and others within the region fuels the market growth.

Europe is the second largest dry eye syndrome market owing to increasing investment of funds for research by government and private players, a well-developed healthcare sector, huge patient pool and growing geriatric population. According to the Saga in 2017, nearly 20% of people living in the Britain are diagnosed with dry eye syndrome. Moreover, it was estimated that one in three people who age 65 or more within the region are diagnosed with this disease. 


Asia Pacific is the fastest growing region for the market due to the presence of economies like India, China, Australia, and others. Moreover, huge patient population, rising expenditure per capita on healthcare boosts the market growth. According to the Australian Institute of Health and Welfare, the total Australian health expenditure from 2015 to 2016 was estimated to be about USD 170.4 billion.


The LAMEA region has the least share in the global dry eye syndrome due to the presence of underdeveloped economies, low per capita healthcare expenditure, stringent government policies, especially within the African region. The Middle East holds the majority of the market of LAMEA region due to a well-developed healthcare sector and huge healthcare expenditure by the developed economies like UAE, Kuwait, Dubai, and others.


Key players:

The key players for the global dry eye syndrome are Allostera Pharma (Canada), I-Med Pharma Inc. (Canada), Santen Pharmaceuticals Co. Ltd., (Japan), AFT pharmaceuticals (New Zealand), Novaliq GmBh (Germany), Allergan (Republic of Ireland), Novartis AG (Switzerland), Otsuka Pharmaceutical Co. Ltd. (Japan), Valent Pharmaceuticals (Canada), Johnson & Johnson Vision (U.S.)


Global market segmentation:


• By type

o Evaporative dry eye syndrome

o Aqueous dry eye syndrome

o Others


• By diagnosis

o Schirmer test

o Eye exam

o Others


• By treatment 

o Nutritional supplements

o Serum eye drops

o Lubricant eye drops

o Anti-inflammatory drugs segments

o Surgery

o Others


• By end user

o Hospitals/clinics

o Ambulatory surgical centers

o Others


By Region


• North America

o U.S.

o Canada

o Mexico


• Europe

o Germany

o UK

o France

o Italy

o Spain

o Rest of Europe


• Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o Rest of Asia-Pacific


• LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest of LAMEA

Research Scope

 

The study for Global dry eye treatment Market Survey and Trend Research 2018 will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2017  Forecast: 2018 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 

Our analyst implement, several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 

The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 


1. Introduction

1.1. Market Definition

1.2. Market Scope


2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions


3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 


4.  Treatment  Overview

4.1. Introduction 

4.2. Market Size & Forecast, 2015 to 2025

4.3. By  treatment 

4.3.1. nutritional supplements

4.3.2. serum eye drops

4.3.3. lubricant eye drops

4.3.4. anti-inflammatory drugs segments

4.3.5. surgery

4.3.6. others

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Regional Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. North America

5.2.1.1. U.S.

5.2.1.2. Canada

5.2.1.3. Mexico 

5.2.2. Europe

5.2.2.1. UK

5.2.2.2. Germany

5.2.2.3. France

5.2.2.4. Italy 

5.2.2.5. Russia

5.2.2.6. Poland

5.2.2.7. Rest of Europe

5.2.3. Asia-Pacific

5.2.3.1. China

5.2.3.2. India

5.2.3.3. Japan

5.2.3.4. Australia

5.2.3.5. South Korea

5.2.3.6. Rest of Asia-Pacific

5.2.4. LAMEA

5.2.4.1. Saudi Arabia

5.2.4.2. UAE

5.2.4.3. South Africa

5.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Manufacturer/ Vendor Profile

6.1. The following attributes will be considered while profiling key manufacturers in this industry: 

6.1.1.1. Company Overview

6.1.1.2. Financial Synopsis

6.1.1.3. Recent Developments

6.1.1.4. R&D Investments (if any)

6.1.1.5. Strategy Overview (Analyst Perspective)

6.1.1.6. Product Portfolio

6.2. Companies Profiled

6.2.1. Allostera Pharma 

6.2.2. I-Med Pharma Inc. 

6.2.3. Santen Pharmaceuticals Co. Ltd.,  

6.2.4. AFT pharmaceuticals 

6.2.5. Novaliq GmBh

6.2.6. Allergan  

6.2.7. Novartis AG 

6.2.8. Otsuka Pharmaceutical Co. Ltd. 

6.2.9. Valent Pharmaceuticals 

6.2.10. Johnson & Johnson Vision

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 


What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

Report ID :240339

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Report ID :240339

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Dry Eye Syndrome Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
  • Impact of COVID on supply/demand scenario, trade landscape & supply chain
  • How market participants are preparing/strategizing to combat the impact
  • How does the short-term & long-term scenario for Dry Eye Syndrome Market looks like

Report ID :240339

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports


  • Data Security
  • Your data is safe and secure


  • Vast Report Database
  • We have more than 2 Million reports in our database


  • Client Focused
  • Personalized updates and 24*7 support


  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support


  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie


  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports